Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

TIRF Objective

By Drug Discovery Trends Editor | March 11, 2010

tirfOlympus, a leader in objective-based total internal reflection fluorescence (TIRF) microscopy, continues to support scientists in their quest for knowledge about living cells with three new high-performance TIRF objectives. The new 150x ultra-magnification objective offers a numerical aperture (NA) of 1.45 for optimal magnification, resolution, light gathering ability and imaging performance.  New 60x and 100x oil immersion objectives have NAs of 1.49.


In all, Olympus now offers five specifically designed TIRF objectives, more than any other manufacturer.  Olympus also is the only company to offer a 150x magnification TIRF lens, along with the world’s highest-NA TIRF objective: the 100x NA 1.65.


The new 150x UAPON NA 1.45 objective is optimized for single molecule TIRF applications. It delivers the high magnification and low background noise necessary for visualizing challenging specimens. The objective delivers crisp images from 340nm ultraviolet (UV) to near-infrared wavelengths and comes with a correction collar to help compensate for aberrations caused by coverglass thickness or variations in immersion media temperatures. The new 100x UAPON NA 1.49 objective also is newly enhanced with a correction collar, and has been updated to include near-UV performance. The 60x APON NA 1.49 provides the brightest high-resolution TIRF images available, thanks to its improved point spread function.


All Olympus TIRF objectives can take full advantage of the recently introduced Olympus cell^TIRF illuminator, which offers four-color, simultaneous, fully motorized control of TIRF excitation along with extraordinary ease of use.


“Scientists doing objective-based TIRF turn to Olympus because we offer nearly a dozen years’ experience designing and using TIRF microscopy to help answer important research questions. Our complement of five TIRF objectives can satisfy the widest range of applications and offers unmatched levels of overall optical performance,” said Nicolas George, Group Marketing Manager – Light Microscopes for Olympus America Inc.


Scientists adopted the TIRF technique to advance understanding of the cell membrane, where vital functions such as communication, absorption, signaling, growth and movement occur. TIRF imaging highlights only the areas of the cell that are in close proximity to the coverglass. Other areas of the cell appear black, and because of this, microscope sensitivity is increased. Olympus TIRF objectives are designed to help researchers more easily produce the evanescent electromagnetic field necessary for TIRF imaging; the objectives are competitively priced and provide the highest NAs overall for TIRF imaging.


Olympus


Filed Under: Drug Discovery

 

Related Articles Read More >

Takeda Pharmaceutical in the Drug Discovery & Development Pharma 50
Takeda’s Takhzyro fares well in pediatric hereditary angioedema study
Novartis in the Pharma 50
Novartis to cut up to 8,000 positions
Gilead Sciences in the Drug Discovery & Development Pharma 50
Gilead resubmits application to FDA for twice-yearly HIV drug lenacapavir
George Floyd mural
How the pandemic and George Floyd made clinical trial diversity a priority

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50